Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revelation Biosciences (REVB)
NASDAQ:REVB
RESEARCH TOOLSreports
Holding REVB?
Track your performance easily
REVB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.70 - $25.26
Previous Close$0.88
Volume49.36K
Average Volume (3M)1.61M
Market Cap
$3.19M
Enterprise Value-$8.89M
Total Cash (Recent Filing)$12.07M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Nov 07, 2024EPS Estimate
-$2.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-28.44
Shares Outstanding1,643,395
10 Day Avg. Volume33,782
30 Day Avg. Volume1,609,189
Standard Deviation0.30
R-Squared0.00053
Alpha-0.13
Financial Highlights & Ratios
Price to Book (P/B)1.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.59
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Revelation Biosciences News
Ownership Overview
1.12% Insiders
0.22% Mutual Funds
<0.01% Other Institutional Investors
98.65% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
REVB FAQ
What was Revelation Biosciences’s price range in the past 12 months?
Revelation Biosciences lowest stock price was $0.70 and its highest was $25.26 in the past 12 months.
What is Revelation Biosciences’s market cap?
Currently, no data Available
When is Revelation Biosciences’s upcoming earnings report date?
Revelation Biosciences’s upcoming earnings report date is Nov 07, 2024 which is 3 days ago.
How were Revelation Biosciences’s earnings last quarter?
Revelation Biosciences released its earnings results on Aug 09, 2024. The company reported -$5.13 earnings per share for the quarter, missing the consensus estimate of -$1.805 by -$3.325.
Is Revelation Biosciences overvalued?
According to Wall Street analysts Revelation Biosciences’s price is currently Overvalued.
Does Revelation Biosciences pay dividends?
Revelation Biosciences does not currently pay dividends.
What is Revelation Biosciences’s EPS estimate?
Revelation Biosciences’s EPS estimate is -$2.84.
How many shares outstanding does Revelation Biosciences have?
Revelation Biosciences has 3,758,055 shares outstanding.
What happened to Revelation Biosciences’s price movement after its last earnings report?
Revelation Biosciences reported an EPS of -$5.13 in its last earnings report, missing expectations of -$1.805. Following the earnings report the stock price went down -8%.
Which hedge fund is a major shareholder of Revelation Biosciences?
Currently, no hedge funds are holding shares in REVB
---
Revelation Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.16%
12-Months-Change
Fundamentals
Return on Equity
-253.32%
Trailing 12-Months
Asset Growth
-23.50%
Trailing 12-Months
Company Description
Revelation Biosciences
Petra Acquisition Inc is a blank check company.
---
REVB Stock 12 Month Forecast
Average Price Target
―Technical Analysis
SELLAS Life Sciences Group
―
ADC Therapeutics
―
TRACON Pharmaceuticals
―
Gritstone bio
―
Best Analysts Covering REVB
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-86.67%
reiterated a buy rating 5 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -86.67% per trade.
---